Kurhan, FarukYavuz, Goknur Ozaydin2025-12-302025-12-3020251359-10531461-727710.1177/135910532513836492-s2.0-105023389863https://doi.org/10.1177/13591053251383649https://hdl.handle.net/20.500.14720/29349This cross-sectional study investigated social appearance anxiety in individuals with Alopecia Areata (AA), a chronic autoimmune condition causing visible, non-scarring hair loss. A total of 129 AA patients and 142 age- and sex-matched healthy controls (18-65 years) completed the Social Appearance Anxiety Scale (SAAS) and the Hospital Anxiety and Depression Scale (HADS); the AA group additionally completed the Dermatology Life Quality Index (DLQI) and a Visual Analog Scale (VAS). SAAS scores were markedly higher in AA than controls (65.32 +/- 8.45 vs 21.45 +/- 9.32, p < 0.001). Within AA, SAAS showed a moderate positive association with perceived severity (VAS; r = 0.304, p < 0.05). HADS-Anxiety/Depression did not differ significantly between groups. In the AA cohort, DLQI averaged 12.3 +/- 5.4 (median 12, IQR 9-16), with 62.8% >= 10 and 10.9% >= 20. DLQI correlated most strongly with perceived severity (VAS; r = 0.45, p < 0.001) and clinical visibility (r = 0.37, p = 0.002), with comparatively smaller associations with lesion count/area (r = 0.26/0.34). Taken together, these findings indicate that AA's psychosocial burden is driven primarily by appearance- and visibility-related factors rather than generalized anxiety/depression or sheer disease extent. Routine dermatologic care should incorporate targeted psychosocial assessment-particularly for patients with visible-site involvement-to facilitate timely support.eninfo:eu-repo/semantics/openAccessAlopecia AreataSocial Appearance AnxietyBody Image DisturbanceQuality of LifeVisual Analog ScaleHospital Anxiety and DepressionChronic Skin DisordersPsychodermatologyArticleQ2Q141319115WOS:001627811500001